SLDB — SOLID BIOSCIENCES INC

Ownership history in Finepoint Capital LP  ·  13 quarters on record

This page tracks every 13F SEC filing in which Finepoint Capital LP reported a position in SOLID BIOSCIENCES INC (SLDB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.28% (2024 Q1)
Avg. % of fund
0.99%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 961,251 — 0% 0.27% $5.4M $5.64
2025 Q3 UNCHANGED 961,251 — 0% 0.34% $5.9M $6.17
2025 Q2 UNCHANGED 961,251 — 0% 0.35% $4.7M $4.87
2025 Q1 UNCHANGED 961,251 — 0% 0.27% $3.6M $3.70
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SLDB price (monthly, adj. close)

Other funds also holding SLDB

As of 2025 Q4 — sorted by position size

Monashee Investment Management LLC 3Y 7Y 4.29% Bain Capital Life Sciences Investors, LLC 3Y 7Y 3.42% Ally Bridge Group (NY) LLC 3Y 2.43% Birchview Capital, LP 3Y 7Y 2.33% Siren, L.L.C. 1.29% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.19% Vestal Point Capital, LP 1.12% Redmile Group, LLC 3Y 7Y 0.77% Knott David M Jr 3Y 0.42% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.34%
← Back to Finepoint Capital LP Holdings